MedTrace Logo

Young ESUS Patient Registry

NCT03185520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2021-02-04

No results posted yet for this study

Summary

This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.

Conditions

  • Embolic Stroke of Undetermined Source

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Kanjana S Perera, MD, FRCPC · McMaster University, Hamilton Health Sciences, and Population Health Research Institute

  • Robert G Hart, MD · McMaster University and Population Health Research Institute

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2020-12-17
Completion
2020-12-17

Countries

  • United States
  • Argentina
  • Australia
  • Canada
  • Chile
  • France
  • Germany
  • Mexico
  • Poland
  • South Africa
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03185520 on ClinicalTrials.gov